Harmonizing efficacy and safety: the potentials of CAR-NK in effectively addressing severe toxicities of CAR-T therapy in mantle cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Harmonizing efficacy and safety: the potentials of CAR-NK in effectively addressing severe toxicities of CAR-T therapy in mantle cell lymphoma

Published:2024-05-27 Issue:9 Volume:110 Page:5871-5872
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Sun Xu¹,Wu Yijun²³,Li He¹,Zhao Ailin¹,Niu Ting¹

Affiliation:

1. Department of Hematology, West China Hospital, Sichuan University

2. Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University

3. Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference19 articles.

1. Advances in CAR T-cell therapy for treating patients with mantle cell lymphoma: a critical appraisal;Amin;Int J Surg,2023

2. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization;Li;Am J Pathol,1999

3. Frontline therapy in mantle cell lymphoma: when clinical trial and real-world data collide;Fenske;J Clin Oncol,2023

4. Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents;Jain;J Hematol Oncol,2023

5. Therapeutic options for relapsed/refractory mantle cell lymphoma;Eyre;Blood,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP